إعلان
إعلان
RAPT
RAPT Therapeutics, Inc. Common Stock
33.62
USDبرعاية
+2.35
+7.54%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
قبل الإفتتاح
33.56
-0.06
-0.18%
تقارير أرباح RAPT
النسبة الإيجابية المفاجئة
RAPT تفوق 17 من 25 آخر التقديرات.
68%
التقرير التالي
بيانات التقرير القادم
٠٤ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.76
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+16.92%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-91.66%
RAPT Therapeutics, Inc. Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, RAPT reported earnings of -0.65 USD per share (EPS) for Q3 25, beating the estimate of -0.94 USD, resulting in a 31.56% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.72% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 المحللين forecast an EPS of -0.76 USD, with revenue projected to reach -- USD, implying an زيادة of 16.92% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were RAPT Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, RAPT Therapeutics, Inc. Common Stock reported EPS of -$0.65, beating estimates by 31.56%, and revenue of $0.00, 0% as expectations.
How did the market react to RAPT Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 2.72%, changed from $28.27 before the earnings release to $29.04 the day after.
When is RAPT Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٤ مارس ٢٠٢٦.
What are the forecasts for RAPT Therapeutics, Inc. Common Stock's next earnings report?
Based on 11
المحللين, RAPT Therapeutics, Inc. Common Stock is expected to report EPS of -$0.76 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان